Novotalk
PrivateLast Round
Seed
Oct 1, 2018
Company Overview
Novotalk operates in Healthcare & Life Sciences and is based in Bnei Brak. Its latest recorded funding round was a Seed round in October 2018.
Novotalk is a health tech company that provides on-demand, self-directed speech and language teletherapy solutions for individuals with speech impairments.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, NLP & Conversational AI, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novotalk Comparables
Compare Novotalk with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BeneTalk Ltd | 84% | |
| Iyaso | 83% | |
| Stamurai | 82% |
For institutional investors. Book with your work email.
Novotalk Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2018 | ||||
| Accelerator | May 23, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novotalk Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
| Mount Sinai Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2018
Seed round led by Mount Sinai Ventures
- May 23, 2017
Received funding from MassChallenge Israel.
For institutional investors. Book with your work email.
Novotalk Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novotalk's valuation, stock price, and market status.
Is Novotalk a public or private company?
Novotalk is a private company.
What is the current stock price of Novotalk?
Novotalk is a private company, so its shares have no public market price. Caplight tracks Novotalk's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novotalk worth (valuation)?
Valuation information for Novotalk is not publicly available.
Can I buy Novotalk stock?
Novotalk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novotalk's last funding round?
Novotalk's most recent funding round was Seed on October 1, 2018.
Who are the main investors in Novotalk?
Key investors in Novotalk include Mount Sinai Ventures.
Will Novotalk IPO soon?
No public IPO plans have been announced for Novotalk.
How can I track Novotalk secondary market activity?
Caplight tracks bids, offers, and trades in Novotalk's shares on secondary markets.